1-3 of 3
Yusuke Nakamura, MD, PhD
Close
Sort by
Journal Articles

Characterization of Tcra and Tcrb Repertoires in Acute Myeloid Leukemia Patients before and after Combined Haploidentical and Umbilical Cord Blood Transplant

Houda Alachkar, PharmD, PhD, Poh-Yin Yew, PhD, Rui Yamaguch, Kazuma Kiyotani, Hongtao Liu, MDPhD, Andrew S. Artz, MD MS, Amittha Wickrema, PhD, Koen van Besien, MD, Michael R Bishop, MD, Satoru Miyano, PhD, Wendy Stock, MD, Yusuke Nakamura, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2503.
https://doi.org/10.1182/blood.V124.21.2503.2503
Published: 2014
Journal Articles

Growth Inhibitory Function Of a Novel T-LAK Cell-Originated Protein Kinase Inhibitor On FLT3-ITD Positive Acute Myeloid Leukemia (AML) Cells

Houda Alachkar, PharmD, PhD, Jae-Hyun Park, PhD, Makoto Nakakido, PhD, Alex Wood, Gordana Raca, MD, PhD, Yo Matsuo, Wendy Stock, MD, Yusuke Nakamura, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1459.
https://doi.org/10.1182/blood.V122.21.1459.1459
Published: 2013
Journal Articles

Validation Study on the Prediction of Response to Imatinib Mesylate in Chronic Myeloid Leukemia (CML) Patients by Genome-Wide cDNA Microarray Analysis.

Yoshitoyo Kagami, MD, PhD, Toyomasa Katagiri, PhD, Yasuyuki Kaneta, PhD, Takasi Tsuruo, PhD, Yusuke Nakamura, MD, PhD, Ryuzou Ohno, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2946.
https://doi.org/10.1182/blood.V104.11.2946.2946
Published: 2004